Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Core Scientific (CORZ) Non Operating Income (2021 - 2025)

Historic Non Operating Income for Core Scientific (CORZ) over the last 5 years, with Q3 2025 value amounting to -$89.1 million.

  • Core Scientific's Non Operating Income rose 7847.1% to -$89.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$601.4 million, marking a year-over-year increase of 5260.65%. This contributed to the annual value of -$1.3 billion for FY2024, which is 40829.2% down from last year.
  • According to the latest figures from Q3 2025, Core Scientific's Non Operating Income is -$89.1 million, which was up 7847.1% from -$910.4 million recorded in Q2 2025.
  • Over the past 5 years, Core Scientific's Non Operating Income peaked at $623.5 million during Q1 2025, and registered a low of -$910.4 million during Q2 2025.
  • For the 5-year period, Core Scientific's Non Operating Income averaged around -$107.8 million, with its median value being -$22.8 million (2022).
  • In the last 5 years, Core Scientific's Non Operating Income tumbled by 1813982.54% in 2022 and then surged by 207400.46% in 2024.
  • Quarter analysis of 5 years shows Core Scientific's Non Operating Income stood at -$25.2 million in 2021, then skyrocketed by 813.49% to $179.7 million in 2022, then crashed by 210.88% to -$199.3 million in 2023, then decreased by 13.09% to -$225.4 million in 2024, then soared by 60.46% to -$89.1 million in 2025.
  • Its Non Operating Income was -$89.1 million in Q3 2025, compared to -$910.4 million in Q2 2025 and $623.5 million in Q1 2025.